Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q1 2014 · 10-Q
Revenue$79.23M$79.23M−17.5% vs Q1 2013 Net Income$5.97M$5.97M+0.6% vs Q1 2013 EPS Diluted$0.45$0.45+4.7% vs Q1 2013 Gross Profit$57,924,000−20.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flow$10,621,000−28.1% Free Cash Flowderived$9,439,000−22.9% Margins · derivedGross margin73.1%−2.3 pt vs Q1 2013
Operating margin12.1%+3.2 pt vs Q1 2013
Net margin7.5%+1.4 pt vs Q1 2013
ended Mar 31, 2014 · filed May 12, 2014 · 42 d after period end